Artificial intelligence has moved quickly from experimentation to real use inside the finance function. Controllers, chief accounting officers and CFOs are being asked to evaluate how AI can support ...

The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...

A unanimous Supreme Court reversed the Federal Circuit and held that Amarin did not plausibly allege that Hikma’s skinny label and marketing actively induced infringement of Vascepa’s ...

In recent weeks, Canada became the first G7 country to approve a generic version of the popular drug Ozempic. Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to ...

Update: Valve have confirmed to RPS that this withdrawal of support for Steam transactions by one of PayPal's acquiring banks "is regarding content on Steam, related to what we’ve previously commented ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...

TrumpRx’s sevenfold formulary expansion positions a government-backed portal as a high-volume generics price aggregator rather than a dispensing pharmacy. Tariff exemptions tied to three-year ...

Americans are unlikely to see generic versions of semaglutide — the active ingredient in Novo Nordisk’s Ozempic and Wegovy — until at least the end of 2031, according to a May 13 NBC News report. Novo ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The day has ...